A recent article published by Seeking Alpha, titled “Supreme Court Decision Is Bullish For Stem Cell Companies,” reviews the recent high court decision that allows medical universities and science foundations to receive federal funding for embryonic stem cell research. Now supported by the federal government, the stem cell industry is anticipated to be a $6.6 billion market by 2016, more than 50% greater than its present size.
To read the complete article, visit: http://seekingalpha.com/article/1120881
Peter Harengel, author of the article, provided an overview of the progress taking place in the industry as companies continue to move forward with their stem cell research. VistaGen Therapeutics, for instance, recently announced a significant advance in its development of LiverSafe 3D™, a human liver cell-based bioassay system designed to predict liver toxicity and drug metabolism before animal or human testing. As with its CardioSafe 3D™ product, this bioassay system was designed to be used with modern medicinal chemistry to generate safer, proprietary chemical variants (“drug rescue variants”) of once-promising drug candidates, as well as identify product failures earlier in the cost curve.
Companies active in stem cell research are now much more attractive for a variety of factors. The election in Washington, D.C. has brought clarity to the health care sector, overall. The major players know what to expect and can now move forward. The recent Supreme Court decision will now focus the attention of many on stem cell research as more federal funding will enter the sector. Also of significance is that the political uncertainty is gone regarding stem cell research.
2013 is poised to introduce a new flood of excitement in this up-and-coming health care market.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
